Laura Flavell, PhD,  —

Recent Posts

• Removing financial barriers to treatment for sickle cell disease
• Masitinib clinical program in SCD awarded €9.2M in France
• Chatting with mothers of children with sickle cell disease
• 1st gene-editing therapy for SCD, called Casgevy, approved in UK
• SCD linked to longer wait for kidney transplant in children, youth
• Coping with parental guilt in sickle cell disease management
• 1st SCD patient soon to be given therapy to restore fetal hemoglobin
• Tackling the enemy of cold weather with sickle cell disease
• Eye condition in SCD as common in children as adults: US study
• VOC-related hospitalizations impair SCD children’s quality of life: Study